London, England, United Kingdom In 1996 was created ProVen VCT, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the London. The company was established in Europe in United Kingdom.
The top activity for fund was in 2007. The usual things for fund are deals in the range of 5 - 10 millions dollars. Comparing to the other companies, this ProVen VCT performs on 31 percentage points more the average number of lead investments. Speaking about the real fund results, this Corporate Investor is 15 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2014.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the ProVen VCT, startups are often financed by Oxford Capital Partners, Amadeus Capital Partners, West Deutsche Landesbank Girozentrale. The meaningful sponsors for the fund in investment in the same round are Beringea, West Deutsche Landesbank Girozentrale, Temasek Holdings. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.
We can highlight the next thriving fund investment areas, such as Health Care, Financial Services. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight BioVex, Abzena plc, Altacor. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Related Funds
| Fund Name | Location |
| Atlantica Ventures | Lagos, Lagos, Nigeria |
| BonVenture | Bayern, Germany, Munich |
| CCFO Investments | Afghanistan, Kabul, Kabul Province |
| Chorus One | Maryland, Rockville, United States |
| Cohen & Steers Inc. | New York, New York, United States |
| Gigoptix | California, San Jose, United States |
| Hairui Bona | China, Hubei, Wuhan |
| Irelandia Investments | County Dublin, Dublin, Ireland |
| Kashen Jinsheng Tianhua | - |
| Kunming Venture Capital | China, Kunming, Yunnan |
| Mahanusa Capital | Indonesia, Jakarta, Jakarta Raya |
| Parcel B | California, San Francisco, United States |
| Republic Labs | New York, New York, United States |
| Samsung Electronics | Seoul, Seoul-t'ukpyolsi, South Korea |
| State Farm Ventures | Bloomington, Illinois, United States |
| Sustainable Performance Group | Mclean, United States, Virginia |
| Telescope Partners | California, San Francisco, United States |
| Tri-State Investment Group | Chapel Hill, North Carolina, United States |
| Village Global | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom |
